except in acute severe asthma management. Tiotropium, the first-choice long-acting bronchodilator in COPD, has been studied in severe asthmatics and in COPD patients with a history of asthma ...

The Spanish COPD guidelines recommend treatment of the mixed COPD–asthma phenotype with ICS and a long-acting bronchodilator (LABD) as a first option to improve lung function, respiratory ...

Beta2 (ß2)-agonist medications are a type of inhaled bronchodilator ... agonists (SABAs) and long-acting ß2-agonists (LABAs) play important—but different—roles in asthma management.

So if your asthma symptoms are persistent and you ... and Blood Institute recommend adding a long-acting bronchodilator, such as salmeterol (Serevent Diskus) or formoterol (Foradil), so ask ...

All included trials of fast-onset, long-acting beta-agonists (alone ... in symptom control compared with bronchodilator-only relievers. Asthma Control Questionnaire scores showed a 4.1 percentage ...

GSK's new long-acting drug candidate for severe asthma, depemokimab ... corticosteroids (ICS), plus at least one additional bronchodilator therapy. "As a physician, it is encouraging to see ...

For patients with asthma, inhaled corticosteroids (ICS) combined with short-acting β agonists (SABA) and ICS combined ...

Bronchodilators include inhalers (short-acting inhaled beta-2-agonists ... taking medications such as quick-relief and ...